Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **urethral sphincter muscle** refers collectively to two distinct anatomical structures—the internal urethral sphincter (smooth, involuntary muscle at the bladder neck) and the external urethral sphincter (striated, voluntary muscle in the deep perineal pouch)[1][2][3][4]. These muscles work together to control the retention and release of urine via the urethra, with the internal sphincter chiefly providing passive continence and the external sphincter providing voluntary control[2][3][4]. The internal sphincter also prevents retrograde semen flow during ejaculation in males[2][4]. Dysfunction or trauma to these muscles can result in urinary incontinence or retention. The term "urethral sphincter muscle tissue" does not refer to a molecular target, but rather to a complex of anatomical muscle structures comprised of smooth and skeletal muscle fibers, and thus is not considered a therapeutic target in the typical pharmacological sense[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urethral sphincter muscle.